Recent advances in small cell lung cancer: the future is now?

Author(s):  
Andrea Luciani ◽  
Miriam Blasi ◽  
Leonardo Provenzano ◽  
Sabrina Zonato ◽  
Daris Ferrari
F1000Research ◽  
2017 ◽  
Vol 6 ◽  
pp. 2110 ◽  
Author(s):  
Samira Shojaee ◽  
Patrick Nana-Sinkam

Lung cancer is the number one cause of cancer-related death in both men and women. However, over the last few years, we have witnessed improved outcomes that are largely attributable to early detection, increased efforts in tobacco control, improved surgical approaches, and the development of novel targeted therapies. Currently, there are several novel therapies in clinical practice, including those targeting actionable mutations and more recently immunotherapeutic agents. Immunotherapy represents the most significant step forward in eradicating this deadly disease. Given the ever-changing landscape of lung cancer management, here we present an overview of the most recent advances in the management of non-small cell lung cancer.


2016 ◽  
Vol 21 (8) ◽  
pp. 910-921 ◽  
Author(s):  
Leora Horn ◽  
Martin Reck ◽  
David R. Spigel

2008 ◽  
Vol 9 ◽  
pp. S37-S44 ◽  
Author(s):  
Aniruddha Choudhury ◽  
Marzia Palma ◽  
Håkan Mellstedt

1996 ◽  
Vol 7 (4) ◽  
pp. 363-385 ◽  
Author(s):  
Glenwood D. Goss ◽  
Simone Dahrouge ◽  
Catherine A. Lochrin

Sign in / Sign up

Export Citation Format

Share Document